Chief Scientific Officer W. Michael Flanagan sold $171K of Atrium Therapeutics, Inc.

Sold$171,402

$72.23Price

2,373Shares

−3%Stake

What RNA did after the filing

Prices for RNA after this filing aren't in yet.

Traded Wed, Jan 7. Filed Fri, Jan 9, 12:12 PM ET, during the session. Not investment advice.